Principal Investigator​

Yulia Landa, PsyD, MS, is an Associate Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. She received her PsyD in Clinical Psychology from the University of Hartford and an MS in Clinical and Translational Investigation from Weill Cornell Graduate School of Medical Sciences. Dr. Landa completed a postdoctoral fellowship in schizophrenia treatment and research at Weill Medical College of Cornell University/NewYork-Presbyterian Hospital and received advanced training in Cognitive Behavioral Therapy (CBT) as a Scholar at the Beck Institute for Cognitive Therapy and Research.  

 

Dr. Landa conducts clinical and translational research focused on developing, evaluating, and implementing psychosocial treatments and services for individuals with psychosis and those at clinical high risk for psychosis (CHR). Her work emphasizes targeted CBT and investigates psychological and psychosocial mechanisms to improve treatment outcomes and inform prevention strategies. She has developed individual, group, and family-based CBT programs for patients experiencing delusions, paranoia, and voice-hearing, and her Group CBT for Delusions is among the first validated CBT for psychosis models in the U.S. Dr. Landa has received multiple grant awards, including a NARSAD Young Investigator Award to support her novel Cognitive Group Treatment for Paranoia and an NIH KL2 Career Development Award for her project CBT for the Prevention of Paranoia in Adolescents at High Risk. She is currently completing an NIMH R34-funded clinical trial of a telehealth adaptation of CBT for individuals at CHR and developing digital therapeutics such as RELATED (Resilience to Adversity Through Education and Dialogue), which helps caregivers learn CBT strategies to support relatives with psychotic symptoms. Her research also focuses on early identification of individuals at CHR and those experiencing a first episode of psychosis (FEP), pathways to care, and the role of clinician-patient communication in treatment engagement. Her NIMH R01-funded study, Early Stage Identification and Engagement to Reduce DUP (EaSIE), aims to reduce the duration of untreated psychosis through systematic screening and an innovative communication model (ComPsych) designed to enhance how psychosis and CHR are discussed with patients and families. To support broad dissemination of CBT for the treatment and prevention of psychosis, Dr. Landa has developed training programs and provides CBTp training to clinicians across the U.S. and internationally.